Avenue Therapeutics, Inc. (ATXI) DCF Valuation

Avenue Therapeutics, Inc. (ATXI) Valoración de DCF

US | Healthcare | Biotechnology | NASDAQ
Avenue Therapeutics, Inc. (ATXI) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Avenue Therapeutics, Inc. (ATXI) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Valoración de Simplify Avenue Therapeutics, Inc. (ATXI) con esta calculadora DCF personalizable! Con Real Avenue Therapeutics, Inc. (ATXI) financieras y entradas de pronóstico ajustable, puede probar escenarios y descubrir el valor razonable de Avenue Therapeutics, Inc. (ATXI) en minutos.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA .0 -5.2 .0 .0 4.1 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 26.3 5.2 3.7 8.0 14.5 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -26.3 -10.4 -3.7 -8.0 -10.5 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 8.7 3.1 3.8 6.7 1.8 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .1 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .4 .2 .4 .2 .4 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 -1.0 .0 .0 -3.0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 1.06 1.06 1.06 1.06 1.06 1.06 1.06 1.06 1.06 1.06
EBITAT -25.9 -10.3 -3.7 4.6 -10.4 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF .7 -6.3 .1 12.5 1.4 -.4 .0 .0 .0 .0
WACC, % 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39
PV UFCF
SUM PV UFCF -.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -2
Equity Value 1
Diluted Shares Outstanding, MM 0
Equity Value Per Share 9.93

What You Will Get

  • Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to generate various scenarios.
  • Real-World Data: Avenue Therapeutics, Inc. (ATXI) financial data pre-loaded to facilitate your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A refined Excel model designed to suit your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, validating strategies, and enhancing efficiency.

Key Features

  • Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for Avenue Therapeutics, Inc. (ATXI).
  • WACC Calculator: Features a pre-built Weighted Average Cost of Capital sheet with adjustable parameters.
  • Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates as needed.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Avenue Therapeutics, Inc. (ATXI).
  • Dashboard and Visualizations: Graphical outputs present key valuation metrics for straightforward analysis.

How It Works

  • Download: Get the pre-built Excel file containing Avenue Therapeutics, Inc. (ATXI) financial data.
  • Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: Watch as intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various forecasts and instantly compare results.
  • Make Decisions: Leverage the valuation insights to inform your investment approach.

Why Choose This Calculator for Avenue Therapeutics, Inc. (ATXI)?

  • Designed for Experts: A sophisticated tool utilized by analysts, CFOs, and healthcare consultants.
  • Comprehensive Data: Avenue Therapeutics’ historical and projected financials preloaded for precision.
  • Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
  • Transparent Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Step-by-step guidance to navigate through the calculations.

Who Should Use This Product?

  • Investors: Accurately assess Avenue Therapeutics, Inc. (ATXI)'s fair value prior to making investment choices.
  • CFOs: Utilize a high-quality DCF model for financial reporting and analysis related to Avenue Therapeutics, Inc. (ATXI).
  • Consultants: Easily customize the template for valuation reports tailored to Avenue Therapeutics, Inc. (ATXI) clients.
  • Entrepreneurs: Acquire knowledge on financial modeling practices employed by leading biotech firms like Avenue Therapeutics, Inc. (ATXI).
  • Educators: Implement it as a teaching resource to illustrate valuation techniques relevant to Avenue Therapeutics, Inc. (ATXI).

What the Template Contains

  • Preloaded ATXI Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.